Publication | Open Access

Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study

VaccinationNovel Polysaccharide AdjuvantControlled Phase 1Viral HepatitisImmunologyHepatitisImmunodominanceDelta InulinTherapeutic VaccineHumoral ImmunityImmunotherapeuticsVaccine DesignMedicineVaccine Research